COVID-19 and cardiovascular disease: from bench to bedside
A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential
consequences on the cardiovascular health of millions of people who survive infection …
consequences on the cardiovascular health of millions of people who survive infection …
COVID-19 and autoimmune diseases
Y Liu, AH Sawalha, Q Lu - Current opinion in rheumatology, 2021 - journals.lww.com
We present a review of the association between COVID-19 and autoimmune diseases,
focusing on similarities in immune responses, cross-reactivity of SARS-CoV-2, the …
focusing on similarities in immune responses, cross-reactivity of SARS-CoV-2, the …
Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality
Abstract Coronavirus disease 2019 (Covid-19) is a worldwide infectious disease caused by
severe acute respiratory coronavirus 2 (SARS-CoV-2). In severe SARS-CoV-2 infection …
severe acute respiratory coronavirus 2 (SARS-CoV-2). In severe SARS-CoV-2 infection …
[HTML][HTML] Complete blood count alterations in COVID-19 patients: A narrative review
M Palladino - Biochemia medica, 2021 - hrcak.srce.hr
Sažetak Coronavirus disease 2019 (COVID-19) pandemic represents a scientific and social
crisis. One of the main unmet needs for coronavirus disease 2019 is its unpredictable …
crisis. One of the main unmet needs for coronavirus disease 2019 is its unpredictable …
[HTML][HTML] The immune response to SARS-CoV-2 and COVID-19 immunopathology–Current perspectives
JL Boechat, I Chora, A Morais, L Delgado - Pulmonology, 2021 - Elsevier
SARS-CoV-2 is a new beta coronavirus, similar to SARS-CoV-1, that emerged at the end of
2019 in the Hubei province of China. It is responsible for coronavirus disease 2019 (COVID …
2019 in the Hubei province of China. It is responsible for coronavirus disease 2019 (COVID …
Two years into the COVID-19 pandemic: lessons learned
SJR da Silva, JCF do Nascimento… - ACS infectious …, 2022 - ACS Publications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible
and virulent human-infecting coronavirus that emerged in late December 2019 in Wuhan …
and virulent human-infecting coronavirus that emerged in late December 2019 in Wuhan …
Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19
Our understanding of protective versus pathological immune responses to SARS-CoV-2, the
virus that causes coronavirus disease 2019 (COVID-19), is limited by inadequate profiling of …
virus that causes coronavirus disease 2019 (COVID-19), is limited by inadequate profiling of …
Sex differences in immune responses
T Takahashi, A Iwasaki - Science, 2021 - science.org
Evidence increasingly indicates that male sex is a risk factor for more severe disease and
death from COVID-19. Male bias in COVID-19 mortality is observed in nearly all countries …
death from COVID-19. Male bias in COVID-19 mortality is observed in nearly all countries …
[HTML][HTML] Single-cell transcriptome analysis highlights a role for neutrophils and inflammatory macrophages in the pathogenesis of severe COVID-19
Cumulative data link cytokine storms with coronavirus disease 2019 (COVID-19) severity.
The precise identification of immune cell subsets in bronchoalveolar lavage (BAL) and their …
The precise identification of immune cell subsets in bronchoalveolar lavage (BAL) and their …
[HTML][HTML] Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms
R Zhu, T Yan, Y Feng, Y Liu, H Cao, G Peng, Y Yang… - Cell research, 2021 - nature.com
The infusion of coronavirus disease 2019 (COVID-19) patients with mesenchymal stem cells
(MSCs) potentially improves clinical symptoms, but the underlying mechanism remains …
(MSCs) potentially improves clinical symptoms, but the underlying mechanism remains …